Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma

SIMPLE SUMMARY: Liver transplantation is a curative treatment option for a subset of patients with hepatocellular carcinoma (HCC). However, about twenty percent of patients develop recurrence in the graft or at extrahepatic sites, which is associated with limited therapeutic options and poor surviva...

Descripción completa

Detalles Bibliográficos
Autores principales: Ossami Saidy, Ramin Raul, Postel, Maximilian Paul, Pflüger, Michael Johannes, Schoening, Wenzel, Öllinger, Robert, Gül-Klein, Safak, Schmelzle, Moritz, Tacke, Frank, Pratschke, Johann, Eurich, Dennis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037838/
https://www.ncbi.nlm.nih.gov/pubmed/33807392
http://dx.doi.org/10.3390/cancers13071617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037838/
https://www.ncbi.nlm.nih.gov/pubmed/33807392
http://dx.doi.org/10.3390/cancers13071617

Ejemplares similares